Claim 50% Off TipRanks Premium and Invest with Confidence
- Unlock hedge-fund level data and powerful investing tools designed to help you make smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis so your portfolio is always positioned for maximum potential
Zhaoke Ophthalmology Ltd. ( (HK:6622) ) just unveiled an update.
Zhaoke Ophthalmology Limited has announced the composition of its board of directors and the roles they hold within the company. The announcement details the members of the board and their respective positions on various committees, which include the Audit, Remuneration, Nomination, Investment, and Executive Committees. This update is crucial for stakeholders as it provides insights into the governance structure and decision-making framework of the company.
More about Zhaoke Ophthalmology Ltd.
Zhaoke Ophthalmology Limited is a company incorporated in the British Virgin Islands and continued in the Cayman Islands, focusing on the ophthalmology industry. The company is listed under the stock code 6622 and is involved in the development and commercialization of treatments for eye diseases.
Average Trading Volume: 2,930,105
Technical Sentiment Signal: Buy
Current Market Cap: HK$1.37B
For a thorough assessment of 6622 stock, go to TipRanks’ Stock Analysis page.